Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic glial progenitor cells

An allogeneic, off-the-shelf, preparation of purified human glial progenitor cells, with potential neuro-regenerative activity. Upon unilateral transplantation into spinal cord demyelinated lesions, the glial progenitor cells may integrate into the spinal cord lesion sites and differentiate into astrocytes and oligodendrocytes. Astrocytes are specialized neuroglial cells that perform many neuroprotective functions. Oligodendrocytes produce myelin and may repair damage in neurodegenerative diseases involving damaged or destroyed oligodendrocytes and myelin deficiency, such as transverse myelitis.
Synonym:allogeneic glial restricted progenitor cells
Q-cells
Abbreviation:GRPs
Search NCI's Drug Dictionary